Peritoneal Membrane Dysfunction in Peritoneal Dialysis Using Metabolomics
NCT ID: NCT03964701
Last Updated: 2019-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
18 participants
OBSERVATIONAL
2019-04-22
2020-04-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
International (Pediatric) Peritoneal Biobank
NCT01893710
A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
NCT00214721
Peritonitis and Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients
NCT01977716
Prevention of Peritonitis in Peritoneal Dialysis
NCT01293799
Cost-effectiveness of Urgent-start Therapies Hemodialysis and Peritoneal Dialysis
NCT03474367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Identification of peritoneal membrane functional status changes over time in immature infants' peritoneal membrane.
Identification of early and accurate markers of peritoneal membrane dysfunction when membrane status is possibly reversible that could predict peritoneal patients at risk for future loss of ultrafiltration and dialysis adequacy of small molecules examined today be PET, KT/V and Cr/Cl (when membrane status is not reversible).
Improve PD survival in infants and children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no interventional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged:1month -20 years
Exclusion Criteria
30 Days
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baxter (Hellas) Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nikoleta Printza
Associate Prof in Paediatric Nephrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikoleta Printza
Role: PRINCIPAL_INVESTIGATOR
Aristotle University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
1st ACADEMIC PEDIATRIC DEPARTMENT
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Yiannis Ntotis
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nikoleta Printza
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
98550
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.